4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-22-013281
Chief Financial Officer sold 553 shares at $23.80 ($13,161)
- Chief Financial Officer acquired 1,352 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schneyer Mark C. Chief Financial Officer | 2022-02-23 | Option exercise | +1,352 | 2,655 | D | ||
| Schneyer Mark C. Chief Financial Officer | 2022-02-23 | Sale | −553 | $23.80 | $13,161 | 2,102 | D |
| Derivatives | |||||||
| Schneyer Mark C. Chief Financial Officer | 2022-02-23 | Option exercise · Restricted Stock Units | +1,352 | 4,059 | D | ||
| Open-market sales · 553 sh · avg $23.80 · $13,161 | |||||||
Loading xslF345X03/doc4.xml…